Back to Reports

Coronavirus (COVID-19) - Medical sector Impact - 04 August 2021

Published: 04 August 2021 Code: GDCOV-TR-X078

Globaldata's report on the impact of COVID-19 on the medical sector includes detailed coverage of medical sector analysis, COVID-19 impact, and sector insights among others.

COVID-19 has spread to over 198 countries with a total of more than 194 million confirmed cases and over 4 million deaths. The number of confirmed cases is the US is over 34 million, with cases again rising after a sustained period of decline. As in many other countries, most new cases are of the Delta variant, with hospitalizations also on the rise (97% of those admitted are unvaccinated). Total COVID-19 vaccine doses administered have now surpassed the total number of confirmed cases, with a total of over 2.9 billion single vaccine doses administered. China leads in the total number of vaccinations, while Canada leads amongst top economies in the percentage of population that has received at least one dose of the vaccine.

A concrete summary of the impact of COVID-19:

  • Hiring prospects appear to have been gradually improving since April 2021
  • Nearly 45% of employees report an increase in productivity during WFH
  • Most offices will return to at least 50% capacity in the next six months
  • 3 in 10 employees prefer to visit their office daily after the pandemic
  • Technology will continue to change the way we work over the next three years
  • Artificial intelligence is driving change in working practices
  • Most respondents continue to work from home full-time

Sector insight:

  • Decreased demand in face masks in North America is leading to factory closures and lay-offs, prompting concerns about the capacity to respond to a possible winter resurgence of cases. Vaccination efforts are succeeding in giving some patients enhanced protection from COVID-19, but immunosuppressed patients continue to be at risk, impacting hospital nosocomial infection policies.COVID-19 testing continues to fall, as admissions fall in countries with successful vaccination programs, shifting the volume of testing to non-hospital settings, to support disease surveillance and track-and-trace efforts
  • The spread of the COVID-19 delta variant has prompted public health officials to respond with new recommendations to deal with increasing case numbers. Load purchasing of respiratory equipment and improved clinical outcomes are expected to be sufficient for the potential surge in patients. GlobalData expects this market segment to reduce in value from $20.7 billion in 2020 to $16.8 billion in 2021
  • Dental practices have been recovering slowly, with private practices able to adapt and innovate quicker than publicly owned dental practices.the latest surveys from the American Dental Association (ADA), there has been a big jump of dental practices that are open, with the number of dental practices rising from 38.5% to 64.6% from the end of 2020 to the week of June 14. 76.3% of opened practices are now reporting they are seeing 86% or higher of their normal patient loads

Download our free report for more detailed insights on the impact of COVID-19 in the medical sector.

Register below for a copy of your FREE report

 

First name is required
Last name is required
Job Title is required
Company is required
Work email is required
Country is required
Industry is required
 Tick here to opt-out of curated industry news, reports, and event updates from GlobalData
By clicking 'Submit' you agree to our Terms & Conditions and consent to us collecting your details for the purposes of your enquiry.
 

GDPR + CCPA Compliant

Personal & transactional information is kept safe from unauthorized use.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Still looking?

Have you explored all of our expert analysis? Uncover your next opportunity with our reports.

Explorer

Access more premium companies when you subscribe to Explorer